Clinical trial
A Phase I/II Study of Cardiac Radioablation for Refractory Ventricular Tachycardia
NCT06593418 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of Cardiac Radioablation for Refractory Ventricular Tachycardia
- Lead sponsor
- Corewell Health East
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- January 31, 2028
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myocardial infarction, ventricular tachycardia